Cannabis finance news

Profits, margins and prices fall as Vitura is hit by rising competition

by Steve Jones August 29, 2024August 29, 2024

Vitura Health delivered a net profit after tax of A$3.3 million in FY24, down 76% on […]

Australian firm ECC Pharm expands footprint in Germany with double acquisition

by Steve Jones August 29, 2024August 29, 2024

Lyphe Australia exits clinic sector, axes MSL team, but sets new course for product growth

by Steve Jones August 29, 2024August 29, 2024

ECS Botanics reports A$2m profit in ‘extremely positive year’

by Steve Jones August 28, 2024August 28, 2024

Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira

by Steve Jones and Martin Lane August 28, 2024January 13, 2025

Vitura Health critic Ben Jansen back in the fold as new CEO is named

by Steve Jones August 27, 2024August 27, 2024

Biolife Group takes strategic stake in AHA Corporate

by Martin Lane August 27, 2024January 13, 2025

Greenfern boss steps down with immediate effect

by Martin Lane August 22, 2024January 13, 2025

Industry pioneer Leafcann calls it a day and goes into liquidation

by Steve Jones August 22, 2024August 22, 2024

Epsilon announces new company secretary, eyes lifting of ASX trading suspension

by Martin Lane August 20, 2024January 13, 2025